New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates: Retrospective analysis published in Journal of Medical Screening suggests that ProFound AI for 2D Mammography could have helped detect 48% of interval cancers and 93% of subgroups that include false-negatives and minimal sign lesions. NASHUA, N.H. – March 31, 2021 – iCAD, Inc. (NASDAQ: ICAD), […]
Read More… from ProFound AI May Reduce Interval Breast Cancer Rates